tirzepatide adverse effects Explained: The Future of Weight Management Tirzepatide vs. Retatrutide: Key Differences

Your healthcare provider may adjust this dosage gradually, with increments up to a maximum of 2.4 mg, maintaining each dose for at least 4 weeks (12)

GLP-1 stands for Glucagon-Like Peptide-1, which is a hormone that stimulates insulin production and reduces appetite

Tirzepatide should not be restarted if pancreatitis is confirmed

[DOI] [PMC free article] [PubMed] [Google Scholar] 6

This is a crucial finding, as Metabolic Dysfunction-Associated Steatohepatitis (MASH) is a major driver of chronic disease and shortened healthspan

Tirzepatide (LY3298176) is a 39-amino acid synthetic peptide and the first approved dual agonist of the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors